| Resumo: | Limitations of current treatments for intervertebral disc (IVD) degeneration encourage the development of tissue engineering approaches. Injectable hydrogels loaded with cells can be used as substitute material for the inner part of the IVD, the nucleus pulposus (NP), and provide an opportunity for minimally invasive treatment of IVD degeneration. The NP is populated by chondrocyte-like cells, therefore, chondrocytes and mesenchymal stem cells (MSC), stimulated to differentiate along the chondrogenic lineage could be used to promote NP regeneration. Herein, it is investigated the in vitro and in vivo response of bone marrow-derived MSC and nasal chondrocytes (NC) to modified gellan gum-based hydrogels. Both ionic- (iGG-MA) and photo-crosslinked (phGG-MA) methacrylated gellan gum showed no cytotoxicity in extraction assays with MSC and NC. Furthermore, the materials did not induce pro-inflammatory responses in endothelial cells. MSC and NC attached and formed a monolayer on the hydrogels surface. Moreover, both cell types could be encapsulated into the hydrogels and remained viable for at least 2 weeks, as observed by live cell staining and histochemistry. Importantly, encapsulated MSC and NC showed signs of in vivo chondrogenesis, in an subcutaneous implantation model. Altogether, the data confirm the potential of modified gellan gum-based materials in NP tissue engineering.
|
|---|